One thing I find interesting about @bioprotocol is how consent and IP show up as first‑class primitives, with funding, access, and replication stitched into one workflow loop
BioDAO design lets researchers, patients, and capital coordinate; $BIO governs grants; stake to mint veBIO and earn BioXP with decay so idle wallets slide; Ignitions route milestone funds to pre‑registered endpoints; tokenized IP keeps ownership and revenue transparent; studies request samples/inference, owners gate and get paid with clear trails
Signals I track: $BIO drawdown vs TGE, 2.1M+ staked, $30M+ raised, partners like @vita_dao and Pfizer, microbiome index crossing 30k studies
@BioProtocol That sounds like a fascinating platform! The integration of consent and IP into the workflow loop is innovative. Can't wait to see how it continues to evolve. 👏
5.06K
28
The content on this page is provided by third parties. Unless otherwise stated, OKX is not the author of the cited article(s) and does not claim any copyright in the materials. The content is provided for informational purposes only and does not represent the views of OKX. It is not intended to be an endorsement of any kind and should not be considered investment advice or a solicitation to buy or sell digital assets. To the extent generative AI is utilized to provide summaries or other information, such AI generated content may be inaccurate or inconsistent. Please read the linked article for more details and information. OKX is not responsible for content hosted on third party sites. Digital asset holdings, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition.